Faculty 2014–2015 Cycle 7

Washington, DC

The American Course on Drug Development and Regulatory Sciences (ACDRS) teaching faculty are science-driven and highly experienced international faculty members with a network of experts in pharmaceutical medicine, medical product development, and regulatory sciences.

Name Affiliation Location
Sir Alasdair Breckenridge, FRSE, FMedSci former MHRA chairman London, United Kingdom
Scott Berry, PhD Berry Consultants Austin, TX
Bruce S. Binkowitz, PhD Merck and Co., Inc. Rahway, NJ
Lauren Black, PhD Charles River Laboratories Baltimore, MD
D. Bruce Burlington, MD Independent Consultant Washington, DC
Joseph Caminiti H4B Catapult Hamilton, NJ
Gregory Campbell, PhD US Food and Drug Administration Silver Spring, MD
Louis R. Cantilena, MD, PhD Medical Strategic Initiatives, LLC Bethesda, MD
Dale Cooke Philly Cook Consulting Philadelphia, PA
Christopher Cox, PhD Merck & Co., Inc. Philadelphia, PA
Tim Coté, MD, MPH Coté Orphan Consulting Washington, DC
Brenda Crowe, PhD Eli Lilly and Company Indianapolis, IN
Theodore Danoff, MD, PhD Clarus Therapeutics Philadelphia, PA
Sara Eggers, PhD US Food and Drug Administration Silver Spring, MD
Patricia Evans, PhD Independent Consultant Los Altos, CA
David W. Feigal, Jr, MD, MPH Arizona State University School of Law San Francisco, CA
Leslie C. Floren, PharmD University of California, San Francisco San Francisco, CA
Joshua Galanter, MD University of California, San Francisco San Francisco, CA
Mark J. Goldberger, MD, MPH AbbVie Washington, DC
Charles T. Gombar, PhD Endo Chadds Ford, PA
Charles Grudzinskas, PhD NDA Partners, LLC Annapolis, MD
Christopher Horvath, DVM, MS, DACVP bluebird bio Cambridge, MA
Florence Houn, MD, MPH, FACP Celgene Washington, DC
Suhasini Iyer, PhD Genentech South San Francisco, CA
Diane K. Jorkasky, MD, FACP Independent Consultant Philadelphia, PA
Kenneth Kaitin, PhD Tufts University Boston, MA
Jerry N. Karabelas, PhD Care Capital Princeton, NJ
Jack Kloeber, PhD Kromite Philadelphia, PA
Richard L. Lalonde, PharmD Pfizer New London, CT
Zili Li, MD, MPH Bill and Melinda Gates Foundation Seattle, WA
Uri Lopatin, MD Assembly Pharmaceuticals San Francisco, CA
John A. Lowe III, PhD JL3Pharma LLC Stonington, CT
Murray M. Lumpkin, MD, MSc Bill and Melinda Gates Foundation Seattle, WA
David Macarios, MBA Lifecell Corporation Bridgewater, NJ
Craig H. Mallinckrodt, PhD Eli Lilly & Company Indianapolis, IN
Jaap Mandema, PhD Quantitative Solutions Menlo Park, CA
Mark Milton, PhD, MSc Novartis Institutes for BioMedical Research Cambridge, MA
Bernard Munos, MBA InnoThink Center for Research in Biomedical Innovation Indianopolis, IN
Mark Noguchi, MBA Genentech South San Francisco, CA
Ralph O'Brien, PhD Case Western Reserve University (retired) Cleveland, OH
Carl C. Peck, MD University of California, San Francisco San Luis Obispo, CA
José Pinheiro, PhD Johnson & Johnson Pharmaceutical Research and Development Chatham, NJ
J. Robert Powell, PharmD Consultant Chapel Hill, North Carolina
William Prucka Eli Lilly & Company Indianapolis, IN
Malcolm Rowland, PhD, DSc University of California, San Francisco United Kingdom
Stephen J. Ruberg, PhD Eli Lilly and Company Indianapolis, IN
Hansjorg Sauer, MS, PhD, JD Biotechnology Industry Organization Washington, DC
David Savello, PhD Xenoport Santa Clara, CA
Brian Smith, PhD Amgen Thousand Oaks, CA
Vikram Sinha, PhD US Food and Drug Administration Silver Spring, MD
Dominic G. Spinella, PhD Biodesix, Inc Boulder, CO
S. Aubrey Stoch, MD Merck and Co., Inc. Rahway, NY
Norman Stockbridge, MD US Food and Drug Administration Silver Spring, MD
Karthik Venkatakrishnan, PhD FCP Takeda Deerfield, IL
Paolo Vicini, PhD Pfizer Global Research and Development San Diego, CA
Kristina Vlaovic, MPH Genentech South San Francisco, CA
Yaning Wang, PhD US Food and Drug Administration Silver Spring, MD
John Warren, JD McDermott Will & Emery LLP Washington, DC

Faculty in other years

See Faculty.